Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Onnipa (Bangkok, Thailand), T. Kawamatawong (Bangkok, Thailand), D. Pitidhammabhorn (Bangkok, Thailand), C. Setthaudom (Bangkok, Thailand). Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction. 5000

Member's Comments

No comment yet.

Related content which might interest you: Eosinophilic airway inflammation in COPD and asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Parameters associated with persistent airflow obstruction in chronic severe asthma Source: Eur Respir J 2004; 24: 122-128 Year: 2004 Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002 Eicosanoids and eosinophilic inflammation of airways in stable COPD. Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 Airway pathology in asthma Source: Eur Respir J 2001; 18: 18S-23S Year: 2001 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 The role of small airways in obstructive airway diseases Source: Eur Respir Rev 2011; 20: 23-33 Year: 2011 Bronchial wall inflammatory cells and signs of remodeling in COPD and asthma Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Small airways disease in asthma with-and without- fixed airflow obstruction and COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017 Proximal and peripheral airway morphologic changes in elderly patients with asthma with fixed airflow obstruction and COPD Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments Year: 2016 Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD Source: Eur Respir J 2012; 40: 1098-1105 Year: 2012 Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Induced sputum and airway inflammation in asthma and COPD Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 The pathological feature of airway inflammation in eosinophilic bronchitis Source: Eur Respir J 2005; 26: Suppl. 49, 282s Year: 2005 The importance of eosinophilic inflammation in COPD exacerbations Source: International Congress 2017 – COPD management Year: 2017 Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial Source: Eur Respir J 2007; 29: 906-913 Year: 2007